Get Connected:


Latest News

Body Type May Influence Diabetes, Heart Disease Risks
Abdominal adiposity seen to increase the risk of type 2 diabetes, coronary heart disease, and cardiovascular risk factors.
A combination of dolutegravir and rilpivirine may reduce pill burden for patients with HIV.
Patients with a respiratory illness treated with intravenous nonsteroidal anti-inflammatory drugs had a 7.2 times greater risk of heart attack.
Less than half of Americans are aware that alcohol consumption is linked to cancer.
Treatment with abatacept observed to be effective in some forms of vasculitis, but not all.
Inotuzumab ozogamicin was granted priority review in patients with acute lymphoblastic leukemia.
Top news of the day from across the healthcare landscape.
Non-elderly cancer survivors are more likely to request a low-cost treatment.
View More >

From the Journals

Having the right evidence, using high-value care, and developing strong incentives to improve payment and delivery systems are among the ways we can improve healthcare.
This analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.
The characteristics of patients who require increases in their basal insulin dose were compared with those requiring no increase following conversion between basal insulin analogues.
Existing levodopa therapies for Parkinson’s disease often provide inadequate symptom control after prolonged treatment. This study assessed the cost-effectiveness of an extended-release carbidopa-levodopa formulation (IPX066).
In our quest to identify the areas and activities that show the greatest positive impact and value in care and outcomes, we must aim to not let good science and evidence get away from us, particularly when considering vaccination.
A new ophthalmic formulation of bimatoprost was found to improve adherence and persistence compared with the original formulation of bimatoprost.
Although naloxone delivery devices are proven to reduce opioid overdoses, challenges persist in increasing the use of these devices in the community setting.
Upcoming Partner Events